.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Apothecary Labs concentrated entirely in Topical, with category share at 100.0% and no spillover into other formats, while Topical sales declined 80.51% year over year and 76.03% month over month. The average Topical price rose 36.69% YoY to $38.66, even as overall brand sales fell 80.51% YoY and 66.17% versus 24 months, implying a price-led mix that coincided with a contraction in unit throughput. The combination of a 100% single-category footprint and simultaneous double-digit YoY and MoM declines indicates overexposure to Topical cyclicality; in British Columbia, the absence of a reported category rank and a 76.03% MoM drop suggest the brand ceded shelf momentum during July 2026.
The shift toward higher average prices (+36.69% YoY) alongside steep volume pressure (Topical sales −80.51% YoY and −76.03% MoM) implies Apothecary Labs traded up on price points while elasticity compressed demand, concentrating risk in a single Topical lane. With Topical at 100.0% of mix in July 2026 and no ranked position reported in British Columbia Topical, the brand’s positioning skews toward a narrower, premiumized niche where incremental price takes outweigh breadth, which likely constrained basket conversion and weakened visibility through July 2026.
Competitive Landscape
Apothecary Labs is ranked #9 in BC Topical in July 2026, slipping 1 position year over year from #8 while falling 3 spots from its peak of #6 reached in June 2026; by contrast, Wildflower climbed from #5 to #2 with 183.8% YoY sales growth and Wildflower Canada dropped from #2 to #5 with a 50.7% YoY sales decline, indicating volatility among leaders. Additional competitive shifts include Proofly holding #1 year over year despite a 6.7% YoY sales dip and Nutra edging to #3 while its sales fell 3.2%, suggesting Apothecary Labs’ three-month slide from #6 to #9 is less about across-the-board outperformance and more about selective surges reshuffling the top tier; the trajectory implies Apothecary Labs risks drifting into the middle pack unless it counters category share concentration at the top two ranks.
Notable Products
CBD Maximum Strength Roll-On Gel (2000mg CBD, 88g) posted a -75.6% month-over-month drop and fell to rank 1 within a narrowed lineup, indicating a steep contraction in its Topical trajectory for July 2026. With only one tracked Topical SKU among the top sellers and no other ranked SKUs posting a countervailing gain above +50% or climbing ranks, the mix is highly concentrated and exposed to single-product volatility. The absence of CBD Maximum Strength Mini Roll-On Gel (1000mg CBD) from the rankings alongside the -75.6% decline in the lead SKU suggests demand consolidation rather than trading up, with July 2026 revenue concentrated in a single item at approximately $1.9k. The pattern implies Apothecary Labs is leaning on a flagship topical without portfolio ballast, signaling a need to diversify or refresh variants to stabilize month-to-month performance.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
